Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Conditions:   Malignant Pleural Effusion;   Malignant Pleural Mesothelioma;   Mesothelioma;   Solid Tumor Intervention:   Drug: RSO-021 Sponsor:   RS Oncology LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials